March 22, 2017, Ras Al Khaimah (UAE):  The Board of Directors of Julphar Gulf Pharmaceutical Industries recommends the distribution of 16 percent cash dividends and 3 percent bonus shares for the year 2016 – subject to the formal approval of the company’s shareholders during the upcoming Annual General Meeting (AGM), which will be held on April 16th, 2017.

Commenting on the Board’s decision, Julphar’s Chairman His Highness Sheikh Faisal Bin Saqr Al Qasimi said: “Last year witnessed economic and political challenges impacting the region. However, we managed to maintain a strong performance, which demonstrates our solid and stable foundation. We are deeply committed to enhance our shareholders’ value and we believe in our long term vision to be the leader in enabling access to quality pharmaceutical products in Middle East and Africa.'

During the meeting, the Board Members also approved the company’s financial statements for the year ended on December 31st, 2016.